A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis
A study to compare rofecoxib versus naproxen in the treatment of Chinese patients with rheumatoid arthritis...
Brief Summary
Official Title: “A Multicenter, Randomized, Parallel-Group, 8-Week, Double-Blind, and Active Comparator-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Rofecoxib Tablet 25 mg Once Daily Versus Naproxen Table 500 mg Twice Daily in the Treatment of Chinese Patient With Rheumatoid Arthritis”
A study to compare rofecoxib versus naproxen in the treatment of Chinese patients with rheumatoid arthritis.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Intervention(s) in this Clinical Trial
- Drug: MK0966; rofecoxib
- Drug: Comparator: naproxen tablet 500 mg
Outcome Measures for this Clinical Trial
Primary Measures
- Tender joint count
- swollen joint count
- patient's global assessment of disease activity
- investigator's global assessment of disease activity
Secondary Measures
- Patient pain asessment
- patient's global assessment of response to therapy
- investigator's global assessment of response to therapy
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Chinese males or females at least 18 years of age with rheumatoid arthritis
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Merck Industry
Overall Clinical Trial Officials and Contacts
Medical Monitor Study Director Merck
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00157872
Study ID Number: 2005_063
ClinicalTrials.gov Identifier: NCT00157872
Health Authority: China: Ministry of Health
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00157872
